跳至主要内容
临床试验/CTRI/2020/02/023231
CTRI/2020/02/023231已完成未知

Comparative evaluation of 4% Articaine used as Inferior Alveolar Nerve Block with Buccal Infiltration and Intraligamentary injection with Buccal and Lingual Infiltration in mandibular molars with Symptomatic Irreversible Pulpitis- A Prospective, Randomized Controlled Trial

Dr Aditi Goel0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with irreversible pulpitis in mandibular first or/and second molars on both right and left sides,
  • Those aged 25-45 yrs,
  • Those in good health, with no previous history of allergy to any kind of local anesthesia, sulphites or other drugs that would alter pain perception,
  • Prolonged response to cold testing with Endo-frost (RoekoLangenace, Germany),
  • A vital coronal pulp on access opening,
  • No history of trauma to the involved tooth

排除标准

  • Patients with periapical pathology or any periapical radiolucency on rediograph
  • Retreatment cases
  • Cases with Non vital pulp
  • Pregnancy or lactating patients
  • Patients unable to give informed consent
  • Those with allergies to local anesthetic agent or sulphites or sulphur drugs
  • Those taking CNS depressants or any analgesic medication within 12 hrs

研究者

发起方
Dr Aditi Goel

相似试验